BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38513382)

  • 1. Vagus nerve stimulation alleviates cardiac dysfunction and inflammatory markers during heart failure in rats.
    Owens MM; Dalal S; Radovic A; Fernandes L; Syed H; Herndon MK; Cooper C; Singh K; Beaumont E
    Auton Neurosci; 2024 Jun; 253():103162. PubMed ID: 38513382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagus nerve stimulation mitigates intrinsic cardiac neuronal remodeling and cardiac hypertrophy induced by chronic pressure overload in guinea pig.
    Beaumont E; Wright GL; Southerland EM; Li Y; Chui R; KenKnight BH; Armour JA; Ardell JL
    Am J Physiol Heart Circ Physiol; 2016 May; 310(10):H1349-59. PubMed ID: 26993230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Titration Is Important to Maximize the Beneficial Effects of Vagal Nerve Stimulation in Chronic Heart Failure.
    Nishizaki A; Sakamoto K; Saku K; Hosokawa K; Sakamoto T; Oga Y; Akashi T; Murayama Y; Kishi T; Ide T; Sunagawa K
    J Card Fail; 2016 Aug; 22(8):631-8. PubMed ID: 27150492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cyclic vagus nerve stimulation has beneficial electrophysiological effects on healthy hearts in the absence of autonomic imbalance.
    Lee SW; Li Q; Libbus I; Xie X; KenKnight BH; Garry MG; Tolkacheva EG
    Physiol Rep; 2016 May; 4(9):. PubMed ID: 27173672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Level Vagus Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular Calcium Handling in Rats With Post-Myocardial Infarction Heart Failure.
    Zhang Y; Chen A; Song L; Li M; Luo Z; Zhang W; Chen Y; He B
    Int Heart J; 2016 May; 57(3):350-5. PubMed ID: 27181040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2014 Nov; 20(11):808-16. PubMed ID: 25187002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagus nerve stimulation mitigates intrinsic cardiac neuronal and adverse myocyte remodeling postmyocardial infarction.
    Beaumont E; Southerland EM; Hardwick JC; Wright GL; Ryan S; Li Y; KenKnight BH; Armour JA; Ardell JL
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(7):H1198-206. PubMed ID: 26276818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant fecal flora observed in guinea pigs with pressure overload is mitigated in animals receiving vagus nerve stimulation therapy.
    Phillips Campbell RB; Duffourc MM; Schoborg RV; Xu Y; Liu X; KenKnight BH; Beaumont E
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G754-G762. PubMed ID: 27562060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Follow-Up of Patients With Heart Failure Receiving Autonomic Regulation Therapy in the ANTHEM-HF Study.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2016 Aug; 22(8):639-42. PubMed ID: 26576716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.
    DiCarlo LA; Libbus I; Kumar HU; Mittal S; Premchand RK; Amurthur B; KenKnight BH; Ardell JL; Anand IS
    ESC Heart Fail; 2018 Feb; 5(1):95-100. PubMed ID: 29283224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
    Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
    Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.
    Anand IS; Konstam MA; Klein HU; Mann DL; Ardell JL; Gregory DD; Massaro JM; Libbus I; DiCarlo LA; Udelson JJE; Butler J; Parker JD; Teerlink JR
    ESC Heart Fail; 2020 Feb; 7(1):75-83. PubMed ID: 31984682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.
    De Ferrari GM; Tuinenburg AE; Ruble S; Brugada J; Klein H; Butter C; Wright DJ; Schubert B; Solomon S; Meyer S; Stein K; Ramuzat A; Zannad F
    Eur J Heart Fail; 2014 Jun; 16(6):692-9. PubMed ID: 24846173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagal Nerve Stimulation Evoked Heart Rate Changes and Protection from Cardiac Remodeling.
    Agarwal R; Mokelke E; Ruble SB; Stolen CM
    J Cardiovasc Transl Res; 2016 Feb; 9(1):67-76. PubMed ID: 26746408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic vagus nerve stimulation attenuates vascular endothelial impairments and reduces the inflammatory profile via inhibition of the NF-κB signaling pathway in ovariectomized rats.
    Li P; Liu H; Sun P; Wang X; Wang C; Wang L; Wang T
    Exp Gerontol; 2016 Feb; 74():43-55. PubMed ID: 26692419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical vagus nerve stimulation augments spontaneous discharge in second- and higher-order sensory neurons in the rat nucleus of the solitary tract.
    Beaumont E; Campbell RP; Andresen MC; Scofield S; Singh K; Libbus I; KenKnight BH; Snyder L; Cantrell N
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H354-H367. PubMed ID: 28476920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial.
    Gold MR; Van Veldhuisen DJ; Hauptman PJ; Borggrefe M; Kubo SH; Lieberman RA; Milasinovic G; Berman BJ; Djordjevic S; Neelagaru S; Schwartz PJ; Starling RC; Mann DL
    J Am Coll Cardiol; 2016 Jul; 68(2):149-58. PubMed ID: 27058909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial.
    Zannad F; De Ferrari GM; Tuinenburg AE; Wright D; Brugada J; Butter C; Klein H; Stolen C; Meyer S; Stein KM; Ramuzat A; Schubert B; Daum D; Neuzil P; Botman C; Castel MA; D'Onofrio A; Solomon SD; Wold N; Ruble SB
    Eur Heart J; 2015 Feb; 36(7):425-33. PubMed ID: 25176942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.